# Lithium Carbonate

NDC: 46708-304
Generic name: Lithium Carbonate
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20161227

FDA application: ANDA079159

## Active ingredients

- LITHIUM CARBONATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-304"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-304
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1800f34-3d67-4b2f-874e-8639b125d853